Gastroesophageal reflux disease increases predisposition to severe COVID‐19: Insights from integrated Mendelian randomization and genetic analysis
Annals of Human Genetics · 2025
DOI: 10.1111/ahg.12584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Human Genetics, 2025. Verfasst von Jingjing Pan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Zhejiang Provincial Centers for Disease Control and Prevention, Hangzhou, China. Hauptthemen laut MEDLINE: COVID-19, Mendelian Randomization Analysis, Gastroesophageal Reflux, Genetic Predisposition to Disease. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Science and Technology Talents Incubation Project of Center for Disease Control and Prevention of Zhejiang Province.
Abstract (Originalsprache)
Objective
This study aims to investigate the potential causal relationship, shared genomic loci, as well as potential molecular pathways and tissue‐specific expression patterns between gastroesophageal reflux disease (GERD) and the risk of hospitalized/severe 2019 coronavirus disease (COVID‐19).
Methods
We employed linkage disequilibrium score regression and bidirectional Mendelian randomization (MR) analysis to explore potential genetic associations between GERD ( N = 602,604) and hospitalized COVID‐19 ( N = 2095,324) as well as severe COVID‐19 ( N = 1086,211). Additionally, shared genomic loci were extracted from common pivotal regions, further confirmed through corresponding colocalization analyses. GERD‐driven molecular pathway network was constructed using extensive literature data mining to understand the molecular‐level impacts of GERD on COVID‐19.
Results
Our results revealed a significant positive genetic correlation between GERD and both hospitalized ( r g = 0.418) and severe COVID‐19 ( r g = 0.314). Furthermore, the MR analysis demonstrated a unidirectional causal effect of genetic predisposition to GERD on COVID‐19 outcomes, including hospitalized COVID‐19 (odds ratio [OR]: 1.33, 95% confidence interval [CI]: 1.27–1.44, p = 9.17e − 12) and severe COVID‐19 (OR: 1.27, 95% CI: 1.18–1.37, p = 1.20e − 05). Additionally, GERD and both COVID‐19 conditions shared one genomic locus with lead‐SNPs rs1011407 and rs1123573, corresponding to the transcription factor BCL11A. Colocalization analysis further demonstrated a significant positive correlation between genome‐wide association study and expression quantitative trait locus (eQTL) abnormalities, including rs1011407 (eQTL_ p = 2.35e − 07) and rs1123573 (eQTL_ p = 2.74e − 05). Molecular pathway analysis indicated that GERD might promote the progression of COVID‐19 by inducting immune‐activated and inflammation‐related pathways.
Conclusion
These findings confirm that genetically determined GERD may increase the susceptibility to hospitalized/severe COVID‐19. The shared genetic loci and the potential molecular pathways offer valuable insights into causal connections between GERD and COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Zhejiang Provincial Centers for Disease Control and Prevention, Hangzhou, China.
- Zhejiang Key Laboratory of Public Health Detection and Pathogenesis Research, Hangzhou, China.
Förderung
- The Science and Technology Talents Incubation Project of Center for Disease Control and Prevention of Zhejiang Province
Zitieren
APA
Pan, J., & Li, J. (2025). Gastroesophageal reflux disease increases predisposition to severe COVID‐19: Insights from integrated Mendelian randomization and genetic analysis. Annals of Human Genetics. https://doi.org/10.1111/ahg.12584
Vancouver
Pan J, Li J. Gastroesophageal reflux disease increases predisposition to severe COVID‐19: Insights from integrated Mendelian randomization and genetic analysis. Annals of Human Genetics. 2025. doi:10.1111/ahg.12584
BibTeX
@article{Pan2025,
author = {Pan, Jingjing and Li, Jianhua},
title = {Gastroesophageal reflux disease increases predisposition to severe COVID‐19: Insights from integrated Mendelian randomization and genetic analysis},
journal = {Annals of Human Genetics},
year = {2025},
doi = {10.1111/ahg.12584}
}
EUVIMED